Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

Recreating the Onsite Experience with the Right Tools – Building Company Culture Virtually

Distance shouldn't hinder collaboration! This video explores how the right technology can bridge the physical gap and recreate the vibrant atmosphere of an in-office environment for your remote team in...

Impactful Advances in Aesthetic Medicine

Press Releases | January 22, 2025 | Medscape Education

Medscape is pleased to announce new advancements within its Clinical Advances in Aesthetic Medicine. Launched in 2022, this initiative has effectively educated MD practitioners, showcasing measurable outcomes with submissions to...

A Pulse on Innovation at the Heart of Cardiology 2025

Press Releases | January 21, 2025 | Medscape Education

MedscapeLIVE! is proud to present its annual Heart of Cardiology meeting, returning for its fifth year in Miami, Florida from January 24-26, 2025. Over 3 packed days at the Fontainebleau...

Innovative Trials appoints first Non-Executive Chair

Press Releases | January 20, 2025 | Innovative Trials

John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth

The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy

Discover the key takeaways from OPEN Health’s latest whitepaper: "The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy."

Defining the “Why” in Virtual Team Settings – Building Company Culture Virtually

Defining your team's purpose in a virtual setting is crucial for success. Are your workflows clear and documentation accessible? Learn how these elements can transform team dynamics and boost productivity,...

Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications

Press Releases | January 16, 2025 | Uniphar

Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.

Artificial Intelligence:  How to approach the ethical cost of innovation

Press Releases | January 15, 2025 | Mednet

In a rapidly evolving industry, staying ahead means embracing new tools thoughtfully. We're setting the gold standard by ethically leveraging AI to drive innovation while ensuring patient trust and regulatory...

How can we navigate the tension between scientific rigor and emotional resonance in brand storytelling?

Press Releases | January 15, 2025 | Mednet

In her first Ask Alex article of the year, Scientific Director, Dr Alexandra Loveday explores the ways our expert writers combine rigorous scientific data with empathetic and engaging content to...